08:00 am - 09:00 am
Opening Keynote
09:00 am - 10:00 am
Breakfast Break
10:00 am - 11:00 am
Regulatory Pathways Panel
10:00 am - 10:30 am
Prof. David R. Nakamura
Memorial Sloan Kettering Cancer Center
Peptide-Drug Conjugates in Solid Tumours: Phase II Trial Update
10:30 am - 11:00 am
Mr. Tobias Lehmann
Technical University of Munich (TUM)
Minimising Aspartimide Formation via Backbone Protection
11:00 am - 12:00 pm
Oral Delivery Innovation
11:00 am - 11:30 am
Dr. Carlos Menéndez
AstraZeneca R&D, Gothenburg
Tunable β-Sheet Hydrogels as Subcutaneous Depots for Weekly Peptide Dosing
11:30 am - 12:00 pm
Ms. Rachel Okonkwo
Peptiform BioSciences Inc.
Navigating FDA 505(b)(2) for Novel Peptide Formulations
12:00 pm - 01:30 pm
Sponsor Talk
12:00 pm - 12:30 pm
Dr. Sophia Hartmann
NovaPeptide Therapeutics GmbH
Welcome to BPS 2026: A Decade of Peptide Innovation
12:30 pm - 01:00 pm
Prof. James O. Adeyemi
University of Cambridge
Engineering Selectivity in GLP-1/GIP Dual Agonists
01:00 pm - 01:30 pm
Mr. Tobias Lehmann
Technical University of Munich (TUM)
Minimising Aspartimide Formation via Backbone Protection
01:30 pm - 01:30 pm
Lunch
02:30 pm - 03:15 pm
Oral Delivery Innovation
03:15 pm - 03:45 pm
Networking Break
×
![]()
Abstract
Bio
08:00 am - 08:30 am
Morning Coffee
08:30 am - 10:30 am
SPPS Technology Session
08:30 am - 09:30 am
Prof. Yuki Tanaka
Osaka University
Enhanced Sampling MD for Flexible Peptide Docking at GPCRs
09:30 am - 10:30 am
Dr. Carlos Menéndez
AstraZeneca R&D, Gothenburg
Tunable β-Sheet Hydrogels as Subcutaneous Depots for Weekly Peptide Dosing
10:30 am - 01:30 pm
Poster Session I — Manufacturing & Purity
10:30 am - 11:00 am
Ms. Rachel Okonkwo
Peptiform BioSciences Inc.
Navigating FDA 505(b)(2) for Novel Peptide Formulations
11:00 am - 11:30 am
Dr. Sophia Hartmann
NovaPeptide Therapeutics GmbH
Welcome to BPS 2026: A Decade of Peptide Innovation
11:30 am - 12:00 pm
Dr. Linh Tran
Lonza AG
Flow Chemistry Integration in Industrial SPPS
12:00 pm - 12:30 pm
Dr. Ivan Petrov
Charité – Universitätsmedizin Berlin
Safety and Tolerability of Stapled Peptide BIM-Mimetics in Haematological Malignancies
12:30 pm - 01:00 pm
Dr. Nadia Volkov
Novo Nordisk A/S
Excipient Screening Strategies for Long-Acting Injectable Peptide Formulations
01:00 pm - 01:30 pm
Dr. Hans Becker
CEM Corporation
Microwave-Assisted SPPS: Speed, Purity, and Scale Considerations
01:30 pm - 02:30 pm
Lunch
02:30 pm - 04:00 pm
Regulatory Pathways Panel
02:30 pm - 03:00 pm
Prof. James O. Adeyemi
University of Cambridge
Engineering Selectivity in GLP-1/GIP Dual Agonists
03:00 pm - 03:30 pm
Dr. Omar Khalil
Sanofi S.A.
EMA Perspectives on Peptide Drug Classification: ATMP vs Small Molecule
03:30 pm - 04:00 pm
Mr. Tobias Lehmann
Technical University of Munich (TUM)
Minimising Aspartimide Formation via Backbone Protection
04:00 pm - 05:00 pm
Networking Break
05:00 pm - 06:00 pm
Sponsor Talk
05:00 pm - 06:00 pm
Dr. Petra Novak
Bachem AG
Racemisation Control at Cys and His Residues in Fmoc SPPS
×
![]()
Abstract
Bio
09:00 am - 09:30 am
Morning Coffee
09:30 am - 10:00 am
Oral Delivery Innovation
09:30 am - 10:00 am
Prof. Yuki Tanaka
Osaka University
Enhanced Sampling MD for Flexible Peptide Docking at GPCRs
10:00 am - 11:00 am
Workshop: Formulation Troubleshooting
10:00 am - 10:30 am
Dr. Ivan Petrov
Charité – Universitätsmedizin Berlin
Safety and Tolerability of Stapled Peptide BIM-Mimetics in Haematological Malignancies
10:30 am - 11:00 am
Prof. David R. Nakamura
Memorial Sloan Kettering Cancer Center
Peptide-Drug Conjugates in Solid Tumours: Phase II Trial Update
11:00 am - 11:30 am
AI & Generative Design Session
11:00 am - 11:30 am
Dr. Carlos Menéndez
AstraZeneca R&D, Gothenburg
Tunable β-Sheet Hydrogels as Subcutaneous Depots for Weekly Peptide Dosing
11:30 am - 12:30 pm
Data Science & Open Benchmarks Panel
11:30 am - 12:00 pm
Ms. Yara Al-Amin
Almac Sciences
HPLC Method Development for Cyclic Peptide Purity Assessment
12:00 pm - 12:30 pm
Dr. Petra Novak
Bachem AG
Racemisation Control at Cys and His Residues in Fmoc SPPS
12:30 pm - 01:30 pm
BD & Licensing Forum
12:30 pm - 01:00 pm
Mr. Tobias Lehmann
Technical University of Munich (TUM)
Minimising Aspartimide Formation via Backbone Protection
01:00 pm - 01:30 pm
Dr. Amara Diallo
PolyPeptide Group
From Lab to cGMP: Lessons from 10 Commercial Peptide Launches
01:30 pm - 02:30 pm
Lunch
02:30 pm - 03:00 pm
Regulatory Pathways Panel
03:00 pm - 04:00 pm
Emerging Therapeutic Areas
03:00 pm - 03:30 pm
Dr. Hans Becker
CEM Corporation
Microwave-Assisted SPPS: Speed, Purity, and Scale Considerations
03:30 pm - 04:00 pm
Dr. Omar Khalil
Sanofi S.A.
EMA Perspectives on Peptide Drug Classification: ATMP vs Small Molecule
×
![]()
Abstract
Bio
01:00 pm - 02:00 pm
Lunch
02:00 pm - 03:00 pm
Sponsor Talk
03:00 pm - 05:00 pm
BD & Licensing Forum
03:00 pm - 03:30 pm
Dr. Ivan Petrov
Charité – Universitätsmedizin Berlin
Safety and Tolerability of Stapled Peptide BIM-Mimetics in Haematological Malignancies
03:30 pm - 04:00 pm
Dr. Nadia Volkov
Novo Nordisk A/S
Excipient Screening Strategies for Long-Acting Injectable Peptide Formulations
04:00 pm - 04:30 pm
Dr. Hans Becker
CEM Corporation
Microwave-Assisted SPPS: Speed, Purity, and Scale Considerations
04:30 pm - 05:00 pm
Dr. Petra Novak
Bachem AG
Racemisation Control at Cys and His Residues in Fmoc SPPS
05:00 pm - 05:30 pm
Networking Break
05:30 pm - 07:00 pm
Poster Session II — Clinical & Translational
05:30 pm - 06:00 pm
Dr. Amara Diallo
PolyPeptide Group
From Lab to cGMP: Lessons from 10 Commercial Peptide Launches
06:00 pm - 06:30 pm
Dr. Linh Tran
Lonza AG
Flow Chemistry Integration in Industrial SPPS
06:30 pm - 07:00 pm
Dr. Omar Khalil
Sanofi S.A.
EMA Perspectives on Peptide Drug Classification: ATMP vs Small Molecule
07:00 pm - 08:00 pm
Networking Gala & Innovation Awards
07:00 pm - 07:30 pm
Prof. James O. Adeyemi
University of Cambridge
Engineering Selectivity in GLP-1/GIP Dual Agonists
07:30 pm - 08:00 pm
Dr. Sophia Hartmann
NovaPeptide Therapeutics GmbH
Welcome to BPS 2026: A Decade of Peptide Innovation
×
![]()
Abstract
Bio
07:00 am - 07:30 am
Morning Coffee
07:30 am - 08:30 am
Oral Delivery Innovation
07:30 am - 08:00 am
Prof. Yuki Tanaka
Osaka University
Enhanced Sampling MD for Flexible Peptide Docking at GPCRs
08:00 am - 08:30 am
Prof. David R. Nakamura
Memorial Sloan Kettering Cancer Center
Peptide-Drug Conjugates in Solid Tumours: Phase II Trial Update
08:30 am - 09:00 am
Breakfast Break
09:00 am - 10:30 am
Oncology Keynote
09:00 am - 09:30 am
Dr. Nadia Volkov
Novo Nordisk A/S
Excipient Screening Strategies for Long-Acting Injectable Peptide Formulations
09:30 am - 10:00 am
Dr. Carlos Menéndez
AstraZeneca R&D, Gothenburg
Tunable β-Sheet Hydrogels as Subcutaneous Depots for Weekly Peptide Dosing
10:00 am - 10:30 am
Dr. Hans Becker
CEM Corporation
Microwave-Assisted SPPS: Speed, Purity, and Scale Considerations
10:30 am - 11:30 am
Data Science & Open Benchmarks Panel
10:30 am - 11:00 am
Dr. Petra Novak
Bachem AG
Racemisation Control at Cys and His Residues in Fmoc SPPS
11:00 am - 11:30 am
Mr. Tobias Lehmann
Technical University of Munich (TUM)
Minimising Aspartimide Formation via Backbone Protection
11:30 am - 12:00 pm
Networking Break
12:00 pm - 01:00 pm
Emerging Therapeutic Areas
12:00 pm - 12:30 pm
Ms. Yara Al-Amin
Almac Sciences
HPLC Method Development for Cyclic Peptide Purity Assessment
12:30 pm - 01:00 pm
Dr. Linh Tran
Lonza AG
Flow Chemistry Integration in Industrial SPPS
01:00 pm - 02:00 pm
Networking Gala & Innovation Awards
01:00 pm - 01:30 pm
Dr. Omar Khalil
Sanofi S.A.
EMA Perspectives on Peptide Drug Classification: ATMP vs Small Molecule
01:30 pm - 02:00 pm
Dr. Amara Diallo
PolyPeptide Group
From Lab to cGMP: Lessons from 10 Commercial Peptide Launches
×
![]()
Abstract
Bio
09:00 am - 09:30 am
Morning Coffee
09:30 am - 11:00 am
Networking Gala & Innovation Awards
09:30 am - 10:00 am
Ms. Rachel Okonkwo
Peptiform BioSciences Inc.
Navigating FDA 505(b)(2) for Novel Peptide Formulations
10:00 am - 10:30 am
Prof. James O. Adeyemi
University of Cambridge
Engineering Selectivity in GLP-1/GIP Dual Agonists
10:30 am - 11:00 am
Dr. Sophia Hartmann
NovaPeptide Therapeutics GmbH
Welcome to BPS 2026: A Decade of Peptide Innovation
11:00 am - 01:00 pm
BD & Licensing Forum
11:00 am - 11:30 am
Ms. Yara Al-Amin
Almac Sciences
HPLC Method Development for Cyclic Peptide Purity Assessment
11:30 am - 12:00 pm
Dr. Petra Novak
Bachem AG
Racemisation Control at Cys and His Residues in Fmoc SPPS
12:00 pm - 12:30 pm
Mr. Tobias Lehmann
Technical University of Munich (TUM)
Minimising Aspartimide Formation via Backbone Protection
12:30 pm - 01:00 pm
Dr. Carlos Menéndez
AstraZeneca R&D, Gothenburg
Tunable β-Sheet Hydrogels as Subcutaneous Depots for Weekly Peptide Dosing
01:00 pm - 02:00 pm
Lunch
02:00 pm - 02:30 pm
Regulatory Pathways Panel
02:30 pm - 03:30 pm
SPPS Technology Session
02:30 pm - 03:00 pm
Prof. Yuki Tanaka
Osaka University
Enhanced Sampling MD for Flexible Peptide Docking at GPCRs
03:00 pm - 03:30 pm
Dr. Ivan Petrov
Charité – Universitätsmedizin Berlin
Safety and Tolerability of Stapled Peptide BIM-Mimetics in Haematological Malignancies
03:30 pm - 04:00 pm
Networking Break
×
![]()
Abstract
Bio
09:00 am - 09:30 am
Morning Coffee
09:30 am - 10:00 am
Sponsor Talk
10:00 am - 12:00 pm
Data Science & Open Benchmarks Panel
10:00 am - 10:30 am
Prof. David R. Nakamura
Memorial Sloan Kettering Cancer Center
Peptide-Drug Conjugates in Solid Tumours: Phase II Trial Update
10:30 am - 11:00 am
Dr. Nadia Volkov
Novo Nordisk A/S
Excipient Screening Strategies for Long-Acting Injectable Peptide Formulations
11:00 am - 11:30 am
Dr. Ivan Petrov
Charité – Universitätsmedizin Berlin
Safety and Tolerability of Stapled Peptide BIM-Mimetics in Haematological Malignancies
11:30 am - 12:00 pm
Prof. Yuki Tanaka
Osaka University
Enhanced Sampling MD for Flexible Peptide Docking at GPCRs
12:00 pm - 12:30 pm
Emerging Therapeutic Areas
12:30 pm - 01:00 pm
Farewell Lunch
01:00 pm - 01:30 pm
Platform Innovation Spotlight
01:30 pm - 03:30 pm
Oncology Keynote
01:30 pm - 02:00 pm
Dr. Carlos Menéndez
AstraZeneca R&D, Gothenburg
Tunable β-Sheet Hydrogels as Subcutaneous Depots for Weekly Peptide Dosing
02:00 pm - 02:30 pm
Dr. Hans Becker
CEM Corporation
Microwave-Assisted SPPS: Speed, Purity, and Scale Considerations
02:30 pm - 03:00 pm
Ms. Yara Al-Amin
Almac Sciences
HPLC Method Development for Cyclic Peptide Purity Assessment
03:00 pm - 03:30 pm
Dr. Petra Novak
Bachem AG
Racemisation Control at Cys and His Residues in Fmoc SPPS
03:30 pm - 04:00 pm
Networking Break
04:00 pm - 05:00 pm
Closing Keynote
×
![]()
Abstract
Bio
[pab_demo_launch]